INVOKANA® is proven to provide better results than Januvia®*

INVOKANA® is available in 100 mg and 300 mg, the starting dose is 100 mg.

Over the course of one year, INVOKANA® 300 mg and Januvia® 100 mg were compared in a head-to-head clinical study where INVOKANA® achieved better results in several areas, including A1C reductions and weight loss.

Indication and Important Safety Information

The most common side effects of INVOKANA® include genital yeast infections, urinary tract infection, and changes in urination.

*Januvia® is a registered trademark of Merck Sharp & Dohme Corp.

get more info

get more information

Interested in INVOKANA®? Register for more information.

save on medications

$0 co-pay every month

For most privately insured patients. Restrictions apply.

ongoing support

ongoing support

Janssen CarePath for INVOKANA® has free support for type 2 diabetes.